Cardiovascular Disease in Gout and the  Protective Effect of Treatments Including Urate-Lowering Therapy

AbstractCardiovascular disease affects more than 90 million Americans. Recent studies support an increased cardiovascular disease risk in inflammatory conditions, such as gout. Increased serum urate levels, or hyperuricemia, are a precursor to gout. Data from meta-analyses have shown hyperuricemia to be linked to hypertension and coronary heart disease. Similarly, gout has been associated with an increased risk of myocardial infarction, cerebrovascular accidents, and death from cardiovascular disease in randomized clinical trials. Urate-lowering therapy reduces serum urate and may decrease systemic inflammation, generation of oxidative species, and reverses endothelial dysfunction through hyperuricemia-dependent or hyperuricemia-independent pathways. Cardioprotective benefits of allopurinol, a first-line agent for the treatment of gout, have been demonstrated to potentially prevent myocardial infarction, stroke, atrial fibrillation, and other cardiovascular diseases in observational studies in select populations. Randomized controlled trials (RCTs)  have also examined the role of newer urate-lowering therapies, such as febuxostat and lesinurad, and their risk of cardiovascular-specific mortality in comparison to allopurinol. A large post-marketing study of febuxostat vs. allopurinol showed higher all-cause and cardiovascular-specific mortalit y in the febuxostat group than in the allopurinol group; a major study limitation was that large numbers of patients were lost to ...
Source: Drugs - Category: Drugs & Pharmacology Source Type: research

Related Links:

No abstract available
Source: The Pediatric Infectious Disease Journal - Category: Infectious Diseases Tags: Your Diagnosis, Please Source Type: research
Sufficient levels of iron in the blood might prevent about 1 in 10 diagnoses of coronary heart disease and reduce mortality risk. The good news: Lots of healthy foods have plenty of iron.
Source: WebMD Health - Category: Consumer Health News Source Type: news
Revel Pharmaceuticals is the result of work funded in large part by the SENS Research Foundation, with the support of its many philanthropic donors. That part of the history of the underlying research isn't covered in today's short article on the company, so it seems worth mentioning here. Cross-links are chemical bonds formed between molecules in the extracellular matrix. Some are necessary to structure and function, but other unwanted cross-links are added over the years, creating stiffness in flexible tissues such as blood vessel walls and skin. In the case of blood vessels, stiffness causes hypertension, and eventual m...
Source: Fight Aging! - Category: Research Authors: Tags: Longevity Industry Source Type: blogs
Researchers say men outnumber women in stroke therapy clinical trials, which means women may end up receiving less effective treatment.
Source: WebMD Health - Category: Consumer Health News Source Type: news
Biopsy slides mistakenly switched; fertility specialist uses own sperm to impregnate patients; parents say daughter's stroke wasn't identified.Medscape Business of Medicine
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news
An experimental patch works to restore function to damaged areas of the heart, which could ward off irregular heartbeats and heart failure.WebMD Health News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news
Source: International Journal of General Medicine - Category: General Medicine Tags: International Journal of General Medicine Source Type: research
A recent Centers for Medicare&Medicaid Services (CMS) study found that medication use is improving among seniors and vulnerable beneficiary populations. Better adherence to medicines used to treat common chronic conditions such as high cholesterol, high blood pressure and diabetes is estimated to have saved the Medicare program between $27B and $46.6B in avoided health care costs between 2013 and 2018.
Source: The Catalyst - Category: Pharmaceuticals Tags: Drug Cost Medicare Ask About Adherence Source Type: news
Condition:   Atrial Fibrillation Intervention:   Other: No intervention, as this was retrospective study. Sponsor:   Aga Khan University Hospital, Pakistan Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Stroke;   Atrial Fibrillation Intervention:   Sponsors:   Sarawak General Hospital;   Sarawak Heart Centre;   Ministry of Health, Malaysia Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Accidents | Allopurinol | Atrial Fibrillation | Cardiology | Cardiovascular | Clinical Trials | Coronary Heart Disease | Drugs & Pharmacology | Gout | Heart | Heart Attack | Heart Disease | Hypertension | Marketing | Stroke | Study